Literature DB >> 14553969

Vascular effects of sildenafil in hypertensive cardiac transplant recipients.

Richard S Schofield1, David G Edwards, Brian T Schuler, Juan Estrada, Juan M Aranda, Daniel F Pauly, James A Hill, Rahul Aggarwal, Wilmer W Nichols.   

Abstract

BACKGROUND: Sildenafil is commonly used in the treatment of erectile dysfunction in hypertensive male cardiac transplant recipients (CTR); however, little is known about the vascular effects of sildenafil in these patients.
METHODS: Central and peripheral arterial blood pressure (BP), heart rate, and brachial artery reactivity were determined in 15 hypertensive male CTR before and after oral sildenafil (50 mg) administration.
RESULTS: Sildenafil improved brachial and aortic systolic BP, pulse pressure, aortic augmentation index, left ventricular tension time index, travel time of the reflected aortic pressure wave, and brachial artery reactivity (P <.01 for each comparison). No patient became hypotensive with sildenafil despite continuation of usual antihypertensive medications.
CONCLUSIONS: Sildenafil (50 mg) is well tolerated in hypertensive CTR and improves BP, aortic augmentation index, and endothelial function. By decreasing the amplitude of the reflected pressure wave and delaying its return to the heart, sildenafil reduces left ventricular afterload and systolic stress.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14553969     DOI: 10.1016/s0895-7061(03)01006-9

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  6 in total

Review 1.  Targeting phosphodiesterase 5 as a therapeutic option against myocardial ischaemia/reperfusion injury and for treating heart failure.

Authors:  Sevil Korkmaz-Icöz; Tamás Radovits; Gábor Szabó
Journal:  Br J Pharmacol       Date:  2017-03-23       Impact factor: 8.739

2.  Potentiation of the NO-cGMP pathway and blood flow responses during dynamic exercise in healthy humans.

Authors:  Jacqueline K Limberg; Katherine R Malterer; J Mikhail Kellawan; William G Schrage; Brad W Wilkins; Wayne T Nicholson; John H Eisenach; Michael J Joyner; Timothy B Curry
Journal:  Eur J Appl Physiol       Date:  2016-12-24       Impact factor: 3.078

Review 3.  Phosphodiesterase 5 inhibition in essential hypertension.

Authors:  Lorenzo Ghiadoni; Daniele Versari; Stefano Taddei
Journal:  Curr Hypertens Rep       Date:  2008-02       Impact factor: 5.369

4.  Association of aortic stiffness and wave reflections with coronary flow reserve in women without obstructive coronary artery disease: An ancillary study from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE).

Authors:  Wilmer W Nichols; Scott J Denardo; Jonathan B Davidson; Tianyao Huo; C Noel Bairey Merz; Carl J Pepine
Journal:  Am Heart J       Date:  2015-08-28       Impact factor: 4.749

Review 5.  Endothelial dysfunction and cardiac allograft vasculopathy.

Authors:  Monica Colvin-Adams; Nonyelum Harcourt; Daniel Duprez
Journal:  J Cardiovasc Transl Res       Date:  2012-11-08       Impact factor: 4.132

6.  Tadalafil attenuates graft arteriosclerosis of aortic transplant in a rat model.

Authors:  Xu Ziqiang; Wang Jingjun; Zheng Jianjian; Liang Yong; Xia Peng
Journal:  Iran J Basic Med Sci       Date:  2015-09       Impact factor: 2.699

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.